Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening
- 1 July 2003
- Vol. 62 (1) , 70-74
- https://doi.org/10.1016/s0090-4295(03)00125-0
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- ERA SPECIFIC BIOCHEMICAL RECURRENCE-FREE SURVIVAL FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 2001
- LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 2001
- Intermediate‐Term Outcome with Radical Prostatectomy for Localized Prostate Cancer: The Cleveland Clinic ExperienceThe Prostate Journal, 2001
- PROSTATE CANCER IN MEN AGE 50 YEARS OR YOUNGER:: A REVIEW OF THE DEPARTMENT OF DEFENSE CENTER FOR PROSTATE DISEASE RESEARCH MULTICENTER PROSTATE CANCER DATABASEJournal of Urology, 2000
- Declining Rates of Extracapsular Extension After Radical Prostatectomy: Evidence for Continued Stage MigrationJournal of Clinical Oncology, 1999
- Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable diseaseUrology, 1999
- Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurementsJAMA, 1997
- A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancerPublished by American Medical Association (AMA) ,1995
- Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screeningPublished by American Medical Association (AMA) ,1993
- Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference rangesJAMA, 1993